Verma S P, Verma Shailendra
Also known as: S P VERMA, VERMA SP, Shailendra Verma
King George's Medical University
0000-0002-6911-9064
About
Dr Shailendra Prasad verma is currently working as Pofessor & Head, Department of Clinical Hematology at prestigious King George’s Medical University Lucknow, UP.
He completed his Post-graduation (MD, Medicine) from King George’s Medical University, Lucknow in 2008. He specialised in Clinical Hematology from JIPMER, Pondicherry in 2014.
He has total 18 years of Experience as faculty and 11 years in Clinical Hematology
He has more than 120 publications in various national and international journals. His areas of special interest are haemophilia and bleeding disorders, Marrow failure syndromes, leukemia and ITP.
He is member of International and national professional bodies like ASH, EHA, ISHBT and API.
He has conducted studies in the field of low dose factor prophylaxis in hemophila A and initiated stem cell transplant at KGMU.
He is also currently principal investigator of ATLAS-OLE trial at KGMU, studying the role of Futisiran in Hemophilia patient with or without inhibit
Employment
-
King George's Medical University Professor2025 - Present
-
King George's Medical University Associate professor2015 - Present
-
King George's Medical University Lacturer2009 - 2015
Education
-
King George's Medical University DM clinical Hematology
Projects & Funding
Projects & funding information is unavailable.
Publications (110)
- miR-451a is a differentially expressed blood-based microRNA in newly diagnosed CML identified by high-throughput profiling Save
- Addressing unmet needs in chronic myeloid leukemia in chronic phase treated with two or more tyrosine kinase inhibitors: insights from literature and Indian clinical practice Save
- Bridging the Gap: Efficacy of Low-Dose Emicizumab in Haemophilia A With or Without Inhibitors Save
- Clinical Features of Acquired Aplastic Anemia Save
- Clinical Profile and Two-Year Outcome of Patients with MDS-5q Save
- Clinical Spectrum and Diagnosis of Inherited Rare Bleeding Disorders: Long-Term Experience From a Haemophilia Treatment Centre Save
- Clinico-Metabolic Profiling Unraveled Key Metabolic Alterations Underlying the Pathophysiology of Chronic Myeloid Leukemia Save
- Combination of cyclosporine and eltrombopag as a first-line therapy in patients with aplastic anemia Save
- Delayed Inhibitor Development in Severe Hemophilia A: Challenging the 20/50 Exposure Paradigm Save
- Effectiveness of Post Physiotherapy Gym Protocol and Sports Activity to Enhancing Fitness, Psychosocial Well-being and Self Confidence in Young Adult Patients With Haemophilia: A Pilot Study Save